Skip to content

Repligen RGEN Accrued liabilities

Accrued liabilities at other companies

Repligen logo
RepligenRGEN
-$12.66M-800%
EAT
Brinker InternationalEAT
-$5.5M+24.7%
Lincoln National logo
Lincoln NationalLNC
-$98M+56.8%
The J.M. Smucker Company logo
The J.M. Smucker CompanySJM
-$140.1M-2.4%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-$7.9M-104%
KKR & Co. logo
KKR & Co.KKR
$19.18B+23.2%

Other financials

Income statement

See full
Revenue$194.3M+14.8%
Gross profit$108.3M+18.5%
Operating income$15.9M+142%
Net income$8.3M+42.9%
EPS (diluted)$0.15+50.0%

Balance sheet

See full
Cash & equivalents$582.7M-16.4%
Total debt$687.6M+346%
Total equity$2.1B+6.0%
Total assets$2.9B+2.8%

Cash flow

See full
Operating cash flow$28.3M+88.6%
CapEx$4.7M+32.2%
Free cash flow$23.6M+106%

Valuation

See full
Market cap$7.45B-7.1%
Enterprise value$7.55B+2.1%
P/E144.9×
P/S10.1×-0.1×

Profitability

See full
Gross margin49.5%+2.7pp
Operating margin1.5%-14.0pp
Net margin17.1%-3.7pp
FCF margin21.2%+6.1pp

Returns & leverage

See full
Return on equity2.5%+1.9pp
Debt / equity0.3×+0.2×
Current ratio9.2×+2.4×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.

The official record: Repligen’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Repligen's accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Repligen's accrued liabilities?
Repligen (RGEN) reported accrued liabilities of -$12.66M in Q1 2026.
How has Repligen's accrued liabilities changed year-over-year?
Repligen's accrued liabilities decreased by 800.3% year-over-year, from $1.81M to -$12.66M.
What does accrued liabilities mean?
Measures the net change in recognized expenses that have been incurred but not yet invoiced or paid. This metric provides insight into the timing of operational costs and the company's short-term liability management.